• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生物可吸收聚合物药物洗脱支架治疗急性心肌梗死:来自 ULLISE 注册研究的观察。

Bioabsorbable-polymer drug-eluting stents in acute myocardial infarction: Insights from the ULLISE registry.

机构信息

Department of Interventional Cardiology and Endovascular Therapeutics, Instituto Cardiovascular de Buenos Aires, Buenos Aires, Argentina.

Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.

出版信息

Catheter Cardiovasc Interv. 2020 Apr 1;95(5):E144-E145. doi: 10.1002/ccd.28689.

DOI:10.1002/ccd.28689
PMID:32294334
Abstract

Limited information is available about the performance of bioabsorbable-polymer drug-eluting stents in the setting of acute myocardial infarction. Patients treated with these stents presenting with acute myocardial infarction are at higher risk of adverse events compared with stable patients. Further clinical trials are needed to fully understand the role of bioabsorbable-polymer drug-eluting stents in patients presenting with acute myocardial infarction.

摘要

关于生物可吸收聚合物药物洗脱支架在急性心肌梗死中的应用效果,目前信息有限。与稳定型患者相比,接受这些支架治疗的急性心肌梗死患者发生不良事件的风险更高。需要进一步的临床试验来全面了解生物可吸收聚合物药物洗脱支架在急性心肌梗死患者中的作用。

相似文献

1
Bioabsorbable-polymer drug-eluting stents in acute myocardial infarction: Insights from the ULLISE registry.生物可吸收聚合物药物洗脱支架治疗急性心肌梗死:来自 ULLISE 注册研究的观察。
Catheter Cardiovasc Interv. 2020 Apr 1;95(5):E144-E145. doi: 10.1002/ccd.28689.
2
First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).首例人体生物可吸收聚合物涂层依维莫司洗脱支架的评估:DESOLVE I 试验(载有依维莫司和生物可吸收聚合物的 DES 治疗原发性冠状动脉病变患者)的影像学和临床结果。
JACC Cardiovasc Interv. 2013 Oct;6(10):1026-34. doi: 10.1016/j.jcin.2013.05.013. Epub 2013 Sep 18.
3
Two-Year Safety and Efficacy of Biodegradable Polymer Drug-Eluting Stent Versus Second-Generation Durable Polymer Drug-Eluting Stent in Patients With Acute Myocardial Infarction: Data from the Korea Acute Myocardial Infarction Registry (KAMIR).生物可降解聚合物药物洗脱支架与第二代耐用聚合物药物洗脱支架治疗急性心肌梗死患者的两年安全性和有效性:来自韩国急性心肌梗死注册研究(KAMIR)的数据。
Clin Cardiol. 2016 May;39(5):276-84. doi: 10.1002/clc.22525. Epub 2016 Mar 30.
4
Effect of biolimus-eluting stents with biodegradable polymer vs bare-metal stents on cardiovascular events among patients with acute myocardial infarction: the COMFORTABLE AMI randomized trial.载有生物可吸收聚合物的依维莫司洗脱支架与金属裸支架对急性心肌梗死患者心血管事件的影响:COMFORTABLE AMI 随机试验。
JAMA. 2012 Aug 22;308(8):777-87. doi: 10.1001/jama.2012.10065.
5
Two-year clinical registry follow-up of endothelial progenitor cell capture stent versus sirolimus-eluting bioabsorbable polymer-coated stent versus bare metal stents in patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction.对接受ST段抬高型心肌梗死直接经皮冠状动脉介入治疗的患者,内皮祖细胞捕获支架与西罗莫司洗脱生物可吸收聚合物涂层支架及裸金属支架的两年临床注册随访。
J Interv Cardiol. 2010 Apr;23(2):101-8. doi: 10.1111/j.1540-8183.2010.00534.x. Epub 2010 Mar 2.
6
Clinical and angiographic outcomes of bioabsorbable vs. permanent polymer drug-eluting stents in Sweden: a report from the Swedish Coronary and Angioplasty Registry (SCAAR).瑞典生物可吸收聚合物与永久性聚合物药物洗脱支架的临床与血管造影结果:来自瑞典冠状动脉血管成形术登记研究(SCAAR)的报告。
Eur Heart J. 2019 Aug 14;40(31):2607-2615. doi: 10.1093/eurheartj/ehz244.
7
Percutaneous Treatment of Unprotected Left Main Disease With Thin-Strut Durable-Polymer or Early Generation Thicker-Strutted and Coated Bioabsorbable-Polymer Drug-Eluting Stents in a Large-Scale Registry.大规模注册研究中应用薄壁持久聚合物或早期代更厚壁涂覆生物可吸收聚合物药物洗脱支架经皮治疗无保护左主干病变
Cardiovasc Revasc Med. 2021 Nov;32:43-49. doi: 10.1016/j.carrev.2020.12.034. Epub 2020 Dec 31.
8
Biodegradable-Polymer Biolimus-Eluting Stents versus Durable-Polymer Everolimus-Eluting Stents at One-Year Follow-Up: A Registry-Based Cohort Study.一年随访期内生物可降解聚合物生物雷帕霉素洗脱支架与耐用聚合物依维莫司洗脱支架的比较:一项基于注册登记的队列研究。
Tex Heart Inst J. 2016 Apr 1;43(2):126-30. doi: 10.14503/THIJ-14-4997. eCollection 2016 Apr.
9
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in patients presenting with acute myocardial infarction: Insight from the ULISSE registry.急性心肌梗死患者应用生物可降解聚合物西罗莫司洗脱支架的 1 年临床结果:ULISSE 注册研究的见解。
Catheter Cardiovasc Interv. 2019 Dec 1;94(7):972-979. doi: 10.1002/ccd.28305. Epub 2019 Apr 29.
10
Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trial.超薄支架可生物降解聚合物西罗莫司洗脱支架与耐用聚合物依维莫司洗脱支架经皮冠状动脉血运重建(BIOSCIENCE):一项随机、单盲、非劣效性试验。
Lancet. 2014 Dec 13;384(9960):2111-22. doi: 10.1016/S0140-6736(14)61038-2. Epub 2014 Sep 1.